Force Degradation Study and Mass Balance

July 15, 2025

What is Force Degradation Study and Mass Balance:

A forced degradation study, also known as stress testing, is a process used in pharmaceutical development to evaluate the stability of drug substances and products by intentionally degrading them under harsh conditions beyond those of accelerated stability testing. This helps in identifying potential degradation pathways, developing stability-indicating analytical methods, and setting appropriate specifications for impurities. 


Purpose of Forced Degradation Studies:

  • Identify Degradation Products:

The primary goal is to expose the drug substance or product to conditions that induce degradation, generating a range of degradation products. 

  • Develop Stability-Indicating Methods:

The study helps in developing and validating analytical methods that can accurately detect and quantify these degradation products, ensuring they are separated from the active pharmaceutical ingredient (API). 

  • Understand Degradation Pathways:

By studying the degradation products and their formation under different conditions, the study helps in understanding the mechanisms by which the drug degrades. 

  • Support Regulatory Submissions:

The results from forced degradation studies are crucial for regulatory submissions, providing evidence of the stability of the drug substance and product. 

  • Assess Product Stability:

The studies assess the overall stability of the drug substance or product under various conditions, including temperature, humidity, light, and pH. 

 

Conditions for Forced Degradation Studies:

  • Hydrolysis (Acid and Base):

The drug substance is exposed to acidic and basic conditions (e.g., using HCl or NaOH) at different temperatures to assess its susceptibility to hydrolysis. For example, exposure of sample for 5-10 days after treatment with suitable acidic and alkaline solutions.

  • Oxidation:

The drug is exposed to an oxidizing agent (e.g., hydrogen peroxide) under various conditions to assess its vulnerability to oxidation. 

  • Photolysis:

The drug is exposed to light (UV and visible) to assess its photolytic degradation. For example, exposure of sample under UV light in a photo stability chamber upto 1.2 million lux hours.

  • Thermal Degradation:

The drug is subjected to elevated temperatures to assess its stability at higher temperatures. For example, 70 degrees centigrade for 7 days.  


Acceptance criteria:


The acceptable level of degradation is usually defined as a percentage of the active ingredient (e.g., 5-30%). It is general practice to achieve at least 10% of degradation in at least two stress conditions.


For the related substance and assay method, peak purity of each analyte shall be evaluated under each of the stress condition. For example, it should be not less than 990.

Specificity, system suitability, precision and interference (from placebo and degradants) shall be evaluated at minimum.

Mass balance should also be checked after performing stress testing through a validated analytical method. For example, it shall be close to 100%.

Massa balance shall be determined through following equation in general:


Mass Balance (%) = (Sum of quantities of parent drug substance (%Assay) and degradation products (% total Impurities) / Initial amount of drug substance (untreated as such product %Assay)) X 100


Regulatory Requirements:

Various Agencies require this report as a part of the original dossier application. Generally speaking, these study reports shall be part of Module 32S43 and 32P53 for the drug substance and the drug products respectively.

Whenever there is a major or critical change is proposed in the analytical methods (viz., Assay by HPLC, Related substance by HPLC/UPLC etc.) during post approval phase of the dossier’s life cycle, this study shall be performed again.


Final Thoughts

Understanding forced degradation and mass balance is essential for anyone involved in method development, regulatory submissions, or pharmaceutical quality control. These studies ensure patient safety, product efficacy, and compliance with regulatory standards.

 

Disclaimer This and other blogs reflects the views of the author and should not be construed to represent any organization’s and/or Agency’s views or policies. We are not liable for any damages, losses, or consequences that may arise from the use of this information or referencing it. The information is provided for academic interest and general information purpose only. Readers must ensure compliance with all applicable regulations and guidelines.